0000885590-15-000001.txt : 20150102 0000885590-15-000001.hdr.sgml : 20150102 20150102160314 ACCESSION NUMBER: 0000885590-15-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141230 FILED AS OF DATE: 20150102 DATE AS OF CHANGE: 20150102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kellen Ari CENTRAL INDEX KEY: 0001595698 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 15501422 MAIL ADDRESS: STREET 1: 700 ROUTE 202 606 NORTH CITY: BRIDGEWATER STATE: NJ ZIP: 08807 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2014-12-30 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001595698 Kellen Ari 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 0 1 0 0 EVP, Company Group Chairman Restricted Share Units 2014-12-30 4 D 0 75000 D Common Shares, no par value 0 0 D Restricted Share Units 2014-12-30 4 A 0 75000 A Common Shares, no par value 225000 75000 D Each Restricted Share Unit represents a contingent right to receive between zero and three common shares, no par value, of Valeant Pharmaceuticals International, Inc. ("Valeant"), subject to performance based vesting criteria. See note (3). Amendment to the original Restricted Share Units ("RSUs") due to change in measurement dates as approved by the Talent and Compensation Committee of the Board of Directors. The performance based RSUs are eligible to vest on the achievement of TSR targets ranging from 10% to 30% over a base price of $107.96 on each of three measurement dates: 25% would vest on October 9, 2018, 50% on January 9, 2019 and 25% on April 9, 2019, with early vesting possible at higher TSR levels. The performance based RSUs are eligible to vest on the achievement of TSR targets ranging from 10% to 30% over a base price of $107.96 on each of three measurement dates: 25% would vest on October 9, 2016, 50% on January 9, 2017 and 25% on April 9, 2017, with early vesting possible at higher TSR levels. Represents the maximum number of Common Shares that may be issued under the RSU award. See note (4). by: Nicholas Zanoni for Ari Kellen 2015-01-02